Taxotere (docetaxel) is an intravenous chemotherapy drug used to treat cancer patients, specifically early stage breast cancer.
Taxotere interferes with the ability of cancer cells to multiply through cellular division.
Taxotere may be given alone or with other chemotherapy medications. Taxotere may also be used after surgery to treat the following:
We are accepting cases only where patients were diagnosed with early stage breast cancer, and six months after their last treatment, were diagnosed with permanent hair loss.
The most prevalent side effect of Taxotere is permanent alopecia, or permanent hair loss. Most women who undergo Taxotere expect that, if a drug presents an abnormally high risk for irreversible hair loss, that they will be informed of this side effect, so that they can make the best decision for their health and wellbeing. This is not the case for many patients that have experienced permanent and disfiguring hair loss after using Taxotere.
Other common side effects of Taxotere include:
Alopecia is a medical condition involving permanent loss of all hair, including eyebrows, and eyelashes. It is now believed that use of Taxotere can cause permanent, not temporary, Alopecia in patients that were prescribed this drug during cancer treatment for a curable breast cancer. Other drugs used to treat breast cancer, such as Taxol, do NOT cause permanent hair loss and work just as well.
Some patients do experience regrowth of hair after Taxotere use, but a percentage never regrow hair over their entire head. Some women are experiencing disfiguring hair loss, in patches, or even total baldness — it seems to be a spectrum of hair loss. However, the damage is so severe, that these mostly young and middle-aged women must now wear a wig or head-scarf. This can lead to emotional damage or emotional distress in patients. Experts suggest that almost 10% – 15% of women who have used Taxotere during their breast cancer treatment have experienced permanent hair loss. You may be one of these and your hair may never grow back, and this is why seeking legal advice is so important for your case.
First, you must obtain your IV infusion records from the facility where you obtained your chemotherapy injections so see if you were given Taxotere or the generic, Docetaxel. You can also ask your doctor to give you the records showing what chemotherapy you were given. Some patients do experience alopecia on their own. However, since approximately 10% of patients using Taxotere experience permanent hair loss, there is a chance that yours could be caused by your use of Taxotere. There are things that Attorney/Former Nurse Dudley will advise you to do in order to determine if Taxotere caused your permanent hair loss. Ultimately, a complete consultation with a legal professional is necessary to make this determination.
Experiencing side effects like hair loss or other symptoms can be scary, traumatic, and painful. You may be overwhelmed and not know where to start. We are here to help. Your first step should be to seek the assistance of a legal professional. An attorney who is experienced in product liability cases or drug cases will be able to look at your case and help you figure out if a lawsuit is the right action for you.
Sanofi-Aventis, a French multinational pharmaceutical company, manufactures Taxotere and distributes the drug world-wide.
Recent evidence indicates that Sanofi-Aventis has known that Taxotere could cause permanent hair loss for at least 10 years. In 2005, Sanofi told the European Medicines Agency (AMS) that permanent hair loss was experienced by some patients into the follow up period of 10 years and 5 months and was observed. After that, Sanofi continued to manufacture the drug without further adequate warnings.
In 2012, Sanofi told Canadian patients in the Cancer Drug Manual that there were cases of poor hair re-growth and persistent hair loss reported. They indicated that the side effects were possibly irreversible. At no time were patients in the United States warned about the particular side effects of using Taxotere and how it could result in permanent hair loss.
According to some medical studies, nearly ten percent of breast cancer patients taking Taxotere have developed some form of permanent hair loss. Now, victims of Taxotere are able to seek monetary compensation from Sanofi, the company who manufactures Taxotere. Approximately 10-15% of women who have used the drug Taxotere during the course of their cancer treatment have reported no hair growth for up to ten years after stopping their use of the drug. These patients are now eligible to seek compensation for their injuries.
Monetary compensation is available for patients who have suffered from hair loss related to Taxotere use. The exact amount of this compensation will depend on your injuries. In many cases, the amount of monetary damages will not be determined for months or even years. Assistance with medical payments or compensation for emotional damage, loss or wages, or psychological damages may also be available. Speaking to attorney is critical in helping you determine how much money you may be eligible for and what you can expect when you file a lawsuit.
Attorney Liz Dudley is currently speaking with clients who were prescribed Taxotere for breast cancer and sustained permanent hair loss. If you are suffering from alopecia in patches, or from complete baldness that has lasted at least 6 months after your last Taxotere treatment, we would like to speak with you. Please see our Do I Qualify page for more information. Alternatively, if you or someone you know have experienced any of these side effects after Taxotere use, please call for a free case review now.